RetinalGenix Technologies Inc.

OTCPK:RTGN Stock Report

Market Cap: US$36.3m

RetinalGenix Technologies Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Jerry Katzman

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure6.2yrs
CEO ownership33.2%
Management average tenureno data
Board average tenure2yrs

Recent management updates

Recent updates

CEO

Jerry Katzman (71 yo)

6.2yrs

Tenure

Dr. Jerry Katzman, M.D. serves as Chairman, President & CEO at Crater Gold Mining Limited. He serves as Chairman, President & CEO at STERIVIEW Technologies Inc. He joined a multi-specialty group practice i...

Board Members

NamePositionTenureCompensationOwnership
Jerry Katzman
CEO, President & Chairman6.5yrsno data33.19%
$ 12.1m
Anatoly Dritschilo
Member of Advisory Board1.2yrsno datano data
Jack Dodick
Member of Medical Advisory Boardno datano datano data
Vinay Mehindru
Independent Director2.6yrsno data0%
$ 0
Herbert Gould
Independent Director5.8yrsno data2.55%
$ 924.6k
Marguerite McDonald
Member of Medical Advisory Boardno datano datano data
Lawrence Yannuzzi
Member of Medical Advisory Boardno datano datano data
Ahmed Mohiuddin
Member of Medical Advisory Board.no datano datano data
Dessislava Boneva
Independent Director1.2yrsno data0.14%
$ 50.2k
Larry Perich
Member of Medical Advisory Board3.1yrsno datano data
Fred Chasalow
Member of Medical Advisory Board1.5yrsno datano data
Stephen Tannenbaum
Member of Business Advisory Board1.3yrsno datano data

2.0yrs

Average Tenure

71yo

Average Age

Experienced Board: RTGN's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/02 02:24
End of Day Share Price 2025/01/15 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

RetinalGenix Technologies Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution